COSCIENS Biopharma Inc (CSCI)

[livendi]

i dont see it that way,i see the future brighter with many different catalysts coming,money in the bank for new trials,the covid pill will be fab bonus if it works out but again the key is other uses for macrilen like tbi,cancer cachexia,lou gehrigs,because aezs burn rate is low ,we keep all sales for macrilen besides usa and canada where we get a commission,again pedi approval is for an unmet need,no way to test kids for ghd,ins will have to pay for it,short term u are right because these things take time but longterm with all the different positive catalysts coming aezs will be a winner longterm,short term without covid we are a little screwed but that can change in 1 day with the right news,again i see the key to aezs success is other uses for macrilen and pedi test but again u cant rush these things,god bless all